Form 4/A for LEXX Lexaria Bioscience Corp.
Accepted 2022-10-18 00:00:00 ET · period of report 2022-10-14 · accession 0001855763-22-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-10-18 | 2022-10-14 | LEXX | Downey Gregory | CFO | P - Purchase | $2.09 | +121 | 1,954 | +7% | +$252.89 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2022-10-14 | P | A | 121 | $2.09 | 1,954 | D | — | — |